BR112012001812A2 - uso de bactérias de ácido lático ou bifidobacterium ou uma mistura dessas - Google Patents

uso de bactérias de ácido lático ou bifidobacterium ou uma mistura dessas

Info

Publication number
BR112012001812A2
BR112012001812A2 BR112012001812A BR112012001812A BR112012001812A2 BR 112012001812 A2 BR112012001812 A2 BR 112012001812A2 BR 112012001812 A BR112012001812 A BR 112012001812A BR 112012001812 A BR112012001812 A BR 112012001812A BR 112012001812 A2 BR112012001812 A2 BR 112012001812A2
Authority
BR
Brazil
Prior art keywords
mixture
lactic acid
bifidobacterium bacteria
bifidobacterium
bacteria
Prior art date
Application number
BR112012001812A
Other languages
English (en)
Other versions
BR112012001812B1 (pt
Inventor
Didier Carcano
Heli Putaala
Kirsti Tiihonen
Nina Rautonen
Pierrie Desreumaux
Remy Burcelin
Rodolphe Barrangou
Sampo Lahtinen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of BR112012001812A2 publication Critical patent/BR112012001812A2/pt
Publication of BR112012001812B1 publication Critical patent/BR112012001812B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112012001812-4A 2009-07-30 2010-07-30 Uso de bactéria para o tratamento da endotoxemiametabólica em mamífero BR112012001812B1 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US22998009P 2009-07-30 2009-07-30
US61/229,980 2009-07-30
US31240010P 2010-03-10 2010-03-10
US61/312,400 2010-03-10
US32194910P 2010-04-08 2010-04-08
US61/321,949 2010-04-08
US32591910P 2010-04-20 2010-04-20
US61/325,919 2010-04-20
PCT/IB2010/053482 WO2011013106A1 (en) 2009-07-30 2010-07-30 Lactic acid bacteria and bifidobacteria for treating endotoxemia

Publications (2)

Publication Number Publication Date
BR112012001812A2 true BR112012001812A2 (pt) 2016-03-15
BR112012001812B1 BR112012001812B1 (pt) 2019-04-16

Family

ID=43125561

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012001812-4A BR112012001812B1 (pt) 2009-07-30 2010-07-30 Uso de bactéria para o tratamento da endotoxemiametabólica em mamífero

Country Status (8)

Country Link
US (2) US9259447B2 (pt)
EP (1) EP2459203B1 (pt)
CN (1) CN102470152A (pt)
BR (1) BR112012001812B1 (pt)
DK (1) DK2459203T3 (pt)
ES (1) ES2708450T3 (pt)
PL (1) PL2459203T3 (pt)
WO (1) WO2011013106A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
FI20116008A0 (fi) * 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
EP2836224A4 (en) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
CN102792919B (zh) * 2012-08-08 2015-09-09 上海交通大学 悉生动物肥胖模型的构建方法及其应用
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
KR20170021350A (ko) 2014-07-01 2017-02-27 프로비 유에스에이, 인코포레이티드 이층 이중 방출 프로바이오틱 정제
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN105456563A (zh) * 2015-12-25 2016-04-06 天津天狮生物发展有限公司 一种改善肠道功能的组合物
WO2018050650A1 (en) * 2016-09-16 2018-03-22 Dupont Nutrition Biosciences Aps Bacteria
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN107787916A (zh) * 2017-10-28 2018-03-13 蚌埠宏瑞园林有限公司 一种预防雏鸭传染性浆膜炎的养殖方法
CN111514129A (zh) * 2020-05-14 2020-08-11 南开大学 Egcg在制备改善或治疗内源性内毒素血症药物或保健食品中的应用
BE1028802B1 (fr) * 2020-11-16 2022-06-14 Le Centre Wallon De Rech Agronomiques Développement d'une composition symbiotique comme un additif d'alimentation pour les porcelets ou les truies gestantes pour moduler le microbiote intestinal des porcelets au temps du sevrage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
EP1409010A4 (en) * 2000-07-03 2005-06-29 Probendo Pty Ltd TREATMENT   OF   endotoxemia   AND   OF   DISORDERS   ASSOCIATED   BY   OF   PROBIOTICS
ES2292744T3 (es) * 2001-02-06 2008-03-16 Societe Des Produits Nestle S.A. Union de endotoxinas por bacterias y bifidobacterias del acido lactico.
US20040096427A1 (en) * 2001-05-03 2004-05-20 Pinaki Panigrahi Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal dysfunctions including inflammation in the gastro-intestinal tract, neonatal necrotizing enterocolitis (nec) and bacterial sepsis
US6942857B2 (en) * 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US20080286254A1 (en) * 2007-05-17 2008-11-20 Kaneka Corporation Composition comprising licorice polyphenol
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
AU2008333718B2 (en) * 2007-12-06 2012-03-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage

Also Published As

Publication number Publication date
PL2459203T3 (pl) 2019-04-30
US9259447B2 (en) 2016-02-16
EP2459203B1 (en) 2018-10-31
DK2459203T3 (en) 2019-02-18
CN102470152A (zh) 2012-05-23
US10543239B2 (en) 2020-01-28
WO2011013106A1 (en) 2011-02-03
ES2708450T3 (es) 2019-04-09
US20120183516A1 (en) 2012-07-19
BR112012001812B1 (pt) 2019-04-16
US20160113976A1 (en) 2016-04-28
EP2459203A1 (en) 2012-06-06

Similar Documents

Publication Publication Date Title
BR112012001812A2 (pt) uso de bactérias de ácido lático ou bifidobacterium ou uma mistura dessas
BR112012018842A8 (pt) composição nutritiva enteral líquida e uso de uma composição nutritiva líquida
EP2705140B8 (de) Neue milchsäurebakterien und diese enthaltende zusammensetzungen
HK1191671A1 (zh) 乾燥乳酸菌和新的組合物
EP2443249A4 (en) DETECTION OF ACID-PRODUCING BACTERIA
EP2393914A4 (en) LUNG TISSUE ENGINEERING
IL217828B (en) Crystalline molecular complex consisting of zeldronate acid, lysine and water, pharmaceutical compositions containing it and uses thereof
GB201013989D0 (en) Biological materials and methods of using the same
ZA201300612B (en) Novel bacteria and methods of use thereof
BRPI1005931A2 (pt) associação de compostos, uso de uma associação, produto em forma de kit, uso de um produto e composição farmacêutica
BRPI0810881A2 (pt) Uso de bactérias do ácido lático selecionadas para redução da aterosclerose
PL2046944T3 (pl) Mieszanina bakterii kwasu mlekowego do wytwarzania bezglutenowych produktów piekarniczych
BRPI1014316A2 (pt) composição, e, uso de uma composição
EP2546330A4 (en) PREPARATION CONTAINING LACTIC ACID BACTERIUM
EP2112219A4 (en) NEW LACTIC ACID BACTERIA
BR112013002123A2 (pt) composição ácida adesiva para limpeza de sanitários e/ou desodorização
HUP0900819A2 (en) Lung tissue culture
HK1221213A1 (zh) 作為消炎、免疫調節和抗增殖劑的新型化合物的新鈣鹽
PL2591102T3 (pl) Procedura specyficznej izolacji całkowitej zawartości dna drobnoustrojów bakteryjnych i zestaw do tego celu
BR112012014028A2 (pt) uso de uma composição
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
HK1221748A1 (zh) 具有腸內腐敗物質的減少作用的雙歧桿菌
HK1178204A1 (zh) 製造酸奶的乳酸菌
EP2464383A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU
BR112013011733A2 (pt) preparações de iorgurte consistentes contendo micro-organismos probióticos não replicativos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/07/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/07/2010, OBSERVADAS AS CONDICOES LEGAIS